Terms: = Prostate cancer AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1 AND Treatment
38 results:
1. Lithocholic acid-tryptophan conjugate (UniPR126) based mixed micelle as a nano carrier for specific delivery of niclosamide to prostate cancer via EphA2 receptor.
Jannu AK; Puppala ER; Gawali B; Syamprasad NP; Alexander A; Marepally S; Chella N; Gangasani JK; Naidu VGM
Int J Pharm; 2021 Aug; 605():120819. PubMed ID: 34166727
[TBL] [Abstract] [Full Text] [Related]
2. Immune Checkpoints, Inhibitors and Radionuclides in prostate cancer: Promising Combinatorial Therapy Approach.
Kgatle MM; Boshomane TMG; Lawal IO; Mokoala KMG; Mokgoro NP; Lourens N; Kairemo K; Zeevaart JR; Vorster M; Sathekge MM
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921181
[TBL] [Abstract] [Full Text] [Related]
3. Sulforaphane Reduces prostate cancer Cell Growth and Proliferation In Vitro by Modulating the Cdk-Cyclin Axis and Expression of the CD44 Variants 4, 5, and 7.
Rutz J; Thaler S; Maxeiner S; Chun FK; Blaheta RA
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218199
[TBL] [Abstract] [Full Text] [Related]
4. LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production.
Han C; Yu G; Mao Y; Song S; Li L; Zhou L; Wang Z; Liu Y; Li M; Xu B
PLoS One; 2020; 15(11):e0240801. PubMed ID: 33137125
[TBL] [Abstract] [Full Text] [Related]
5. Preclinical anticancer studies on the ethyl acetate leaf extracts of Datura stramonium and Datura inoxia.
Nasir B; Baig MW; Majid M; Ali SM; Khan MZI; Kazmi STB; Haq IU
BMC Complement Med Ther; 2020 Jun; 20(1):188. PubMed ID: 32552791
[TBL] [Abstract] [Full Text] [Related]
6. Distinct tumor microenvironments of lytic and blastic bone metastases in prostate cancer patients.
Ihle CL; Provera MD; Straign DM; Smith EE; Edgerton SM; Van Bokhoven A; Lucia MS; Owens P
J Immunother Cancer; 2019 Nov; 7(1):293. PubMed ID: 31703602
[TBL] [Abstract] [Full Text] [Related]
7. Identification of Novel Biomarkers of Homologous Recombination Defect in DNA Repair to Predict Sensitivity of prostate cancer Cells to PARP-Inhibitors.
Criscuolo D; Morra F; Giannella R; Cerrato A; Celetti A
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31242618
[TBL] [Abstract] [Full Text] [Related]
8.
Kilinc K; Demir S; Turan I; Mentese A; Orem A; Sonmez M; Aliyazicioglu Y
Nutr Cancer; 2020; 72(2):273-282. PubMed ID: 31184219
[TBL] [Abstract] [Full Text] [Related]
9. KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells.
Metzger E; Wang S; Urban S; Willmann D; Schmidt A; Offermann A; Allen A; Sum M; Obier N; Cottard F; Ulferts S; Preca BT; Hermann B; Maurer J; Greschik H; Hornung V; Einsle O; Perner S; Imhof A; Jung M; Schüle R
Nat Struct Mol Biol; 2019 May; 26(5):361-371. PubMed ID: 31061526
[TBL] [Abstract] [Full Text] [Related]
10. An image-guided radiotherapy decision support framework incorporating a Bayesian network and visualization tool.
Hargrave C; Deegan T; Bednarz T; Poulsen M; Harden F; Mengersen K
Med Phys; 2018 Jul; 45(7):2884-2897. PubMed ID: 29772061
[TBL] [Abstract] [Full Text] [Related]
11. A Molecular Modeling Study of the Hydroxyflutamide Resistance Mechanism Induced by Androgen Receptor Mutations.
Liu HL; Zhong HY; Song TQ; Li JZ
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28832499
[TBL] [Abstract] [Full Text] [Related]
12. The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells.
Morra F; Merolla F; Napolitano V; Ilardi G; Miro C; Paladino S; Staibano S; Cerrato A; Celetti A
Oncotarget; 2017 May; 8(19):31815-31829. PubMed ID: 28415632
[TBL] [Abstract] [Full Text] [Related]
13. Bioactivity of arid region honey: an in vitro study.
Hilary S; Habib H; Souka U; Ibrahim W; Platat C
BMC Complement Altern Med; 2017 Mar; 17(1):177. PubMed ID: 28356100
[TBL] [Abstract] [Full Text] [Related]
14. Regulation of protein kinase C-related kinase (PRK) signalling by the TPα and TPβ isoforms of the human thromboxane A
O'Sullivan AG; Mulvaney EP; Kinsella BT
Biochim Biophys Acta Mol Basis Dis; 2017 Apr; 1863(4):838-856. PubMed ID: 28108419
[TBL] [Abstract] [Full Text] [Related]
15. Epigenetic modulation of AR gene expression in prostate cancer DU145 cells with the combination of sodium butyrate and 5'-Aza-2'-deoxycytidine.
Fialova B; Luzna P; Gursky J; Langova K; Kolar Z; Trtkova KS
Oncol Rep; 2016 Oct; 36(4):2365-74. PubMed ID: 27499010
[TBL] [Abstract] [Full Text] [Related]
16. Hybrid Enzalutamide Derivatives with Histone Deacetylase Inhibitor Activity Decrease Heat Shock Protein 90 and Androgen Receptor Levels and Inhibit Viability in Enzalutamide-Resistant C4-2 prostate cancer Cells.
Rosati R; Chen B; Patki M; McFall T; Ou S; Heath E; Ratnam M; Qin Z
Mol Pharmacol; 2016 Sep; 90(3):225-37. PubMed ID: 27382012
[TBL] [Abstract] [Full Text] [Related]
17. NF-κB Mediates the Expression of TBX15 in cancer Cells.
Arribas J; Cajuso T; Rodio A; Marcos R; Leonardi A; Velázquez A
PLoS One; 2016; 11(6):e0157761. PubMed ID: 27327083
[TBL] [Abstract] [Full Text] [Related]
18. KAT8 Regulates Androgen Signaling in prostate cancer Cells.
Kim JY; Yu J; Abdulkadir SA; Chakravarti D
Mol Endocrinol; 2016 Aug; 30(8):925-36. PubMed ID: 27268279
[TBL] [Abstract] [Full Text] [Related]
19. Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cells.
Makarević J; Tawanaie N; Juengel E; Reiter M; Mani J; Tsaur I; Bartsch G; Haferkamp A; Blaheta RA
J Cell Mol Med; 2014 Jul; 18(7):1460-6. PubMed ID: 24779401
[TBL] [Abstract] [Full Text] [Related]
20. Different effect of sodium butyrate on cancer and normal prostate cells.
Paskova L; Smesny Trtkova K; Fialova B; Benedikova A; Langova K; Kolar Z
Toxicol In Vitro; 2013 Aug; 27(5):1489-95. PubMed ID: 23524101
[TBL] [Abstract] [Full Text] [Related]
[Next]
